These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2125000)

  • 21. Marked increase in gastric acid secretory capacity after omeprazole treatment.
    Waldum HL; Arnestad JS; Brenna E; Eide I; Syversen U; Sandvik AK
    Gut; 1996 Nov; 39(5):649-53. PubMed ID: 9026477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are enterochromaffinlike cell tumours reversible? An experimental study on gastric carcinoids induced in Mastomys by histamine2-receptor blockade.
    Wängberg B; Nilsson O; Theodorsson E; Modlin IM; Dahlström A; Ahlman H
    Regul Pept; 1995 Mar; 56(1):19-33. PubMed ID: 7770630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric carcinoid tumours associated with hypergastrinaemia and pernicious anaemia--regression of tumors by antrectomy. A case report.
    Richards AT; Hinder RA; Harrison AC
    S Afr Med J; 1987 Jul; 72(1):51-3. PubMed ID: 3603295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of ECL cells and gastric neoplasia.
    Waldum HL; Brenna E; Sandvik AK
    Yale J Biol Med; 1998; 71(3-4):325-35. PubMed ID: 10461363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of
    Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
    Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion.
    Cui G; Waldum HL
    World J Gastroenterol; 2007 Jan; 13(4):493-6. PubMed ID: 17278212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
    Hage E; Hendel L; Gustafsen J; Hendel J
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antisecretory drugs, hypergastrinemia and hyperplasia of enterochromaffin-like cells (ECL)].
    Andriulli A; Mangia A; Lawson F
    Minerva Gastroenterol Dietol; 1991; 37(3):135-40. PubMed ID: 1686409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The achlorhydria-carcinoid sequence: role of gastrin.
    Creutzfeldt W
    Digestion; 1988; 39(2):61-79. PubMed ID: 3044896
    [No Abstract]   [Full Text] [Related]  

  • 30. Somatostatin receptor regulation of gastric carcinoid tumours.
    Tang LH; Modlin IM
    Digestion; 1996; 57 Suppl 1():11-4. PubMed ID: 8813459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours.
    Modlin IM; Lawton GP; Miu K; Kidd M; Luque EA; Sandor A; Tang LH
    Ann R Coll Surg Engl; 1996 Mar; 78(2):133-8. PubMed ID: 8678447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Action of somatostatin analogue (SMS 201-995) on the growth-promoting effect resulting from sustained achlorhydria in rat gastric mucosa, with special reference to endocrine cell behaviour.
    Cadiot G; Lehy T; Bonfils S
    Eur J Clin Invest; 1988 Aug; 18(4):360-8. PubMed ID: 3139421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gastrin and gastrin receptor].
    Chiba T
    Nihon Rinsho; 1996 Apr; 54(4):1083-6. PubMed ID: 8920678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiulcer drugs and gastric cancer.
    Waldum HL; Gustafsson B; Fossmark R; Qvigstad G
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S39-44. PubMed ID: 16184420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrin effects on isolated rat enterochromaffin-like cells following long-term hypergastrinaemia in vivo.
    Andersson N; Rhedin M; Peteri-Brunbäck B; Andersson K; Cabero JL
    Biochim Biophys Acta; 1999 Sep; 1451(2-3):297-304. PubMed ID: 10556584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personal review: is profound acid inhibition safe?
    Waldum HL; Brenna E
    Aliment Pharmacol Ther; 2000 Jan; 14(1):15-22. PubMed ID: 10632641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.
    Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D
    Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.
    Ono M; Sato H; Kazumori H; Yuki M; Rumi MA; Ortega-Cava CF; Ishihara Y; Ishihara S; Adachi K; Kinoshita Y
    J Lab Clin Med; 2003 Dec; 142(6):364-71. PubMed ID: 14713888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gastrin hypothesis. Implications for antisecretory drug selection.
    Karnes WE; Walsh JH
    J Clin Gastroenterol; 1990; 12 Suppl 2():S7-12. PubMed ID: 2246496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.